Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · February 14, 2024

Impact of the Timing of Cutaneous Immune-Related Adverse Events on Survival Outcomes in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Timing of cutaneous immune-related adverse events impacts survival in cancer patients treated with immune-checkpoint inhibitors: A multi-institutional cohort study
J Am Acad Dermatol 2024 Jan 28;[EPub Ahead of Print], H Rashdan, S Zhang, G Wan, N Nguyen, K Roster, A Rajeh, K Tang, W Chen, C Moseley, S Chen, N LeBoeuf, YR Semenov

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading